Marshall Financial Group (Maryland)’s West Pharmaceutical WST Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $210K | Sell |
948
-12
| -1% | -$2.66K | 0.04% | 246 |
|
2025
Q1 | $215K | Sell |
960
-52
| -5% | -$11.6K | 0.05% | 219 |
|
2024
Q4 | $331K | Sell |
1,012
-1
| -0.1% | -$327 | 0.08% | 173 |
|
2024
Q3 | $304K | Buy |
+1,013
| New | +$304K | 0.07% | 181 |
|
2022
Q2 | – | Sell |
-2,248
| Closed | -$923K | – | 216 |
|
2022
Q1 | $923K | Buy |
2,248
+16
| +0.7% | +$6.57K | 0.38% | 93 |
|
2021
Q4 | $1.05M | Sell |
2,232
-12
| -0.5% | -$5.63K | 0.39% | 92 |
|
2021
Q3 | $953K | Buy |
2,244
+96
| +4% | +$40.8K | 0.49% | 64 |
|
2021
Q2 | $771K | Buy |
+2,148
| New | +$771K | 0.42% | 75 |
|